Nebulized Bupivacaine Analgesia for Cleft Palate Repair

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Cleft Palate

In brief

In this study we introduce a potent local anesthetic; bupivacaine 0.5% in 0.5 mg/kg dose by nebulization as a preemptive analgesia to compare efficacy and safety in children with cleft palate repair.

Key facts

Study ID

NCT04928352

Run by

Assiut University

People needed

60

Starts

2021-06-14

Expected to finish

2026-09-20

Last updated by the study team

2026-01-02

Who can join

Age: 1 and older, up to 7. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children (age 1-7 years) of American Society of Anaesthesiologists physical status (ASA) I-II
• Elective cleft palate repair ± cleft lip surgery under general anesthesia .

You may not qualify if…

• Coronary artery disease
• Hypertension
• Developmental delay
• Allergy to study drug

Where it is running

• Assiut university hospital — Asyut, Assuit, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.